Hydroxyethylapocupreine

Although sulfanilamide and sulfapyridine work wonders in the treatment of pneumonia, they sometimes bring on a train of after-effects both irritating and dangerous, including vomiting, violent headaches, acute anemia. Last week Dr. Mark McDonough Bracken of Pittsburgh's Mellon Institute reported another "miracle drug" for treatment of pneumonia, cheaper than and just as effective as sulfanilamide and sulfapyridine, but much safer. No kin to the older drugs, tongue-tripping hydroxy-ethylapocupreine is derived from quinine, is usually swallowed in gelatin capsules. Of 500 pneumonia patients treated at Pittsburgh's Mercy Hospital, said Chief Physician William Watt Graham MacLachlan, less than 23% died. Usual Pittsburgh pneumonia-case death rate: 45%. Before advising other physicians to lay in a winter's supply of hydroxyethylapocupreine, the cautious investigators, remembering the unqualified praise which greeted sulfanilamide, are waiting for further confirmation of the drug's efficacy.

This file is automatically generated by a robot program, so reader's discretion is required.